Drug Profile
Research programme: distamycin derivatives
Alternative Names: Distamycin derivatives - research programmeLatest Information Update: 06 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 22 Nov 1999 New profile
- 22 Nov 1999 Preclinical development for Cancer in Italy (Unknown route)